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1. Introduction 
Worldwide, nearly 8 million premature deaths, 54% of stroke cases and 47% of ischemic 
heart disease cases were attributable to high blood pressure (BP >115 mm Hg systolic) 
(Ruilope, 2011). It is widely known that arterial hypertension has effects on target organs 
like the brain, the heart and the kidney. Now a large body of evidence on the crucial role of 
subclinical organ damage in determining cardiovascular risk in individuals with and 
without high blood pressure is available. New evidence showed that inflammation and 
activation of immunity are central features in the pathogenesis of atherosclerosis and also in 
hypertension-induced target organ damage. Recent studies have demonstrated that 
macrophages and various T-cell subtypes play a pivotal role in the regulation of blood 
pressure and target organ damage (Muller, 2011). A powerful promoter of inflammation 
and one of the major mediators of hypertension-induced target organ damage is also 
Angiotensin (Ang) II (Kvakan, 2009). European guidelines for the management of arterial 
hypertension from 2007 defined target organ damage by the presence of any of the 
following: 
- electrocardiographic left ventricular hypertrophy (LVH) (Sokolow–Lyon > 38 mm; 
Cornell >2440 mm x ms) 
- echocardiographic LVH (left ventricle mass index in men ≥ 126 g/m2 and in women ≥ 
110 g/m2) 
- carotid wall thickening (IMT > 0.9 mm) or plaque 
- ankle/brachial index <0.9  
- slight increase in plasma creatinine 
- males: 115–133 μmol/l (1.3-1.5 mg/dl) 
- females: 107–124 μmol/l (1.2-1.4 mg/dl) 
- Low estimated glomerular filtration rate (< 60 ml/min/1.73 m2) or creatinine clearance 
< 60 ml/min 
- Microalbuminuria 30-300 mg/24 h or albumin–creatinine ratio: ≥22 (males); or ≥31 
(females) mg/g creatinine 
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Since then, other studies proposed home blood pressure to be as reliable as ambulatory 
monitoring in predicting hypertension-induced target-organ damage, because it is superior 
to carefully taken office measurements (Viazzi, 2002; Stergiou, 2007). Marinakis et al. have 
demonstrated a relationship between heart rate variability and TOD, thus highlighting its 
importance in the genesis of subclinical cardiovascular disease (Marinakis, 2003). Recently, 
inflammation, and in particular tumor necrosis factor-α (TNF-α), has been implied in the 
cascade leading to TOD in patients with essential hypertension (Navarro-Gonzalez, 2008). 
Another study proposed the maximum value of home blood pressure to be a novel indicator 
of target organ damage in hypertension (Matsui, 2011). 
Remodeling of small resistance arteries is also considered an early sign of target organ damage 
in hypertension (Cheng, 2010). The microcirculation is recognized as the site where the 
earliest manifestations of cardiovascular disease, especially inflammatory responses, that 
may play a pivotal role in driving the atherosclerotic process in conduit vessels, occur 
(Lockhart, 2009). Endothelial dysfunction is a predictor of a series of cardiovascular diseases 
(Heitzer et al, 2001; Halcox et al, 2002), although data on hypertension are still scarce 
(Taddei et al, 2002). Furthermore, techniques available for investigating endothelial response 
to various stimuli are invasive, laborious and time consuming. Finally, methods are not yet 
standardized and no certainty exists, that endothelial function assessed in an organ is 
representative of other vascular territories. However, current studies on circulating markers 
of endothelial activity and on endothelial cell progenitors are promising (Werner et al, 2005). 
This could facilitate evaluation of their prognostic role on a larger scale for more widespread 
clinical use. Although not traditionally considered a target organ, arterial blood vessels 
represent the site for the development of the atherosclerotic process that causes 
cardiovascular events.  
Remodeling of large arteries during essential hypertension is also an early sign of organ 
damage. There are a number of noninvasive screening tests to identify structural and 
functional abnormalities of large arteries in arterial hypertension. By the time symptoms 
develop or clinical signs of atherosclerosis can be detected in conduit vessels, the disease 
process is already at an advanced stage (McVeigh, 2004; Lockhart, 2009). Remodeling of 
large arteries is characterized by an increase in intima-media thickness (IMT) aimed for 
maintaining circumferential wall stress, lumen enlargement of proximal elastic arteries, and 
no change in the lumen diameter of distal muscular arteries. Measurement of IMT by 
ultrasound examination of carotid arteries, and identification of atherosclerotic plaques, are 
predictors of both stroke and myocardial infarction (Salonen et al, 1993, Bots et al, 1997; 
Hodis et al, 1998, O`Leary et al, 1999). There is evidence that in untreated hypertensive 
patients without target organ damage, these alterations are common and therefore carotid 
ultrasound examination can detect structural damage at an early stage by routine 
examination. The relationship between increased carotid IMT and cardiovascular events is 
known, and value of IMT in the common carotid artery > 0.9 mm is considered the cut-point 
to emphasize the existence of structural abnormalities also in coronary arteries (Graf, 2009). 
Increased carotid IMT may be related to intimal or medial hypertrophy or both, and may be 
an adaptive response to changes in flow, wall tension, or lumen diameter (Vaudo, 2000). It is 
likely that ultrasound examination limited to the common carotid artery measures vascular 
hypertrophy only, while the evaluation and examination of bifurcation atherosclerosis 
and/or internal carotid artery, where plaques are most common, are more reliable for IMT 
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estimation. The presence of atheromatous plaques can be identified by the presence of focal 
increased thickness of 0.5 mm or 50% of the surrounding IMT (Zanchetti et al, 2002; 
Zanchetti et al, 2004).  
Low ankle-arm index below 0.9 indicates the presence of peripheral arterial disease and, in 
general, advanced atherosclerosis (Feringa et al, 2006), while the measurement of carotid 
IMT can detect early changes (Zanchetti et al, 2002). However, a low ankle-arm index 
correlates with further development of angina, myocardial infarction, heart failure, need for 
coronary bypass's, stroke, need for carotid surgery and peripheral vascular level (Hiatt et al, 
2001, Vogt et al, 1993) and in patients with multivessel coronary involvement it confers 
additional risk (Burek, 1999).  
In the last 10 years, a large amount of data has been accumulated on large artery compliance 
and pulse wave reflection phenomenon, which have been identified as the most important 
pathophysiological determinants of isolated systolic hypertension and increased pulse wave 
velocity (Safar et al, 2003). Measurement of arterial compliance by vascular diameter 
changes in relation to changes in blood pressure is complex and unsuitable for clinical use. 
On the other hand, pulse wave velocity measurement between femoral-carotid arteries 
provides detailed non-invasive assessment of arterial compliance, which is simple and 
rigorous enough to be considered a procedure (Laurent et al, 2006). This determination is an 
independent predictor for overall mortality and cardiovascular morbidity, coronary events 
and strokes in patients with uncomplicated essential hypertension (Laurent et al, 2001, 
Boutouyrie et al, 2002, Laurent et al, 2003; Willum-Hansen et al, 2006). Although the 
relationship between aortic stiffness and coronary events is continuous, a threshold value > 
12 m/s for pulse wave velocity suggests significant alterations of aortic elastic function in 
middle-aged hypertensives (Mancia, 2007).  
Several methods for detecting vascular lesions cannot be clinically used for a variety of 
reasons. An elevated media-to-lumen ratio of small resistance arteries dissected from gluteal 
subcutaneous tissue is an indicator of increased cardiovascular risk (Rizzoni et al, 2003). 
These measurements can demonstrate early changes in diabetes and hypertension 
(Korsgaard et al, 1993, Park et al, 2001; Rizzoni et al, 2001, Schofield et al, 2002) and have 
predictive value for cardiovascular morbidity and mortality (Rizzoni et al, 2003), but the 
invasive character of the method makes this approach unsuitable for general use. Increased 
calcium content in coronary arteries, measured by high resolution cardiac CT was also 
validated by prospective studies as predictor of cardiovascular disease but its availability is 
limited due to high costs (Greenland et al, 2003). 
Other diagnostic procedures such as magnetic resonance, cardiac scintigraphy, coronary 
angiography and exercise testing are reserved for specific indications. Chest X-ray can be a 
useful additional diagnostic method, when dyspnea is the main symptom or when looking 
for information on large intrathoracic arteries of the pulmonary circulation. 
In recent years, an increased interest was given to assessment of cardiac fibrosis. Basic 
techniques have used echoreflectivity (Ciulla et al., 1997; Hoyt et al., 1984). Reversed 
dispersion method (backscattering signal) may reflect to some extent the contractile 
properties of the myocardium more than collagen content, while echoreflectivity more 
directly correlates with histologically measured fibrosis. Echoreflectivity showed that left 
ventricular hypertrophy may vary and that drugs that promote its regression may differ in 
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reducing fibrosis (Ciulla et al, 2004). Now, the most accurate method of assessing cardiac 
tissue composition is nuclear magnetic resonance, whose cost, however, prevents its 
widespread use. Also, tissue collagen component markers are currently under investigation 
(Ciulla et al, 2004), but they have been shown to only partially derive from cardiac tissue. 
2. Hypertension-induced retinal damage 
Hypertension, if not controlled, causes injuries to blood vessels and thereby causes 
alterations also in the retinal microcirculation. Advanced retinopathy is nowadays 
confirmed as hypertension-induced target organ damage (Cohuet, 2006). Signs of 
hypertensive retinopathy are frequently seen in adults 40 years and older, and are predictive 
for stroke, congestive heart failure, and cardiovascular mortality—independently from 
traditional risk factors (Wong, 2007). Mild hypertensive retinopathy signs, such as 
generalized and focal retinal arteriolar narrowing and arteriovenous kinking, are weakly 
associated with systemic vascular diseases. Moderate hypertensive retinopathy signs, such 
as isolated microaneurysms, hemorrhages and cotton-wool spots, are strongly associated 
with subclinical cerebrovascular disease and predict incident clinical stroke, congestive 
heart failure and cardiovascular mortality, independent from blood pressure and other 
traditional risk factors (Wong, 2005). Clinically, signs of hypertensive retinopathy were 
classified into four grades of increasing severity (Keith, 1974). The correlation between 
retinal vascular modifications and the severity of hypertension supports the importance of 
using fundus oculi to improve the diagnosis and to predict future cardiovascular events 
(Porta, 2005). In fact, assessment of hypertensive retinopathy signs for risk stratification is 
supported by international hypertension management guidelines, including the US Joint 
National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood 
Pressure (JNC) and the British Society of Hypertension (Williams, 2004; Chobanian, 2003). 
The pathophysiological mechanism of hypertensive retinopathy is not completely 
established. It seems that elevated blood pressure and other pathogenic mechanisms may be 
involved, such as increased oxidative stress or low-grade inflammation. Retinopathy lesions 
have been associated with hyperglycemia, hypertension, endothelial dysfunction and 
inflammation in different studies (Wong, 2007). Many studies have linked signs of 
hypertensive retinopathy with cognitive decline, cerebral white-matter lesions identified by 
cerebral MRI, lacunar infarctions, cerebral atrophy, and stroke mortality (Wong, 2002; Kwa, 
2002; Wong, 2003; Mitchell, 2005; Wong, 2007). Today, retinal examination offers an 
excellent way to study non-invasively the effects of common vascular risk factors on small 
vessels and possibly for gaining a better understanding of the pathophysiological processes 
involved in cerebral small vessel disease (Doubal, 2009). 
3. Hypertension-induced cardiac damage 
Electrocardiogram is part of all routine assessment of subjects with arterial hypertension. Left 
ventricular hypertrophy (LVH) is one of the earlier manifestations of TOD and constitutes a 
powerful predictor of cardiovascular events (Agabiti-Rose, 1998). This simple test provides 
useful information on conduction disturbances and ischemic heart disease, conditions that 
might urge the performance of additional investigations and influence the choice of 
antihypertensive drugs. A main advantage of ECG is to allow the detection of left 
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ventricular hypertrophy (LVH) (Larsen, 2002; Alfakih, 2006; Waeber, 2009). Sensitivity for 
identifying left ventricular hypertrophy is increased but still Sokolow-Lyon index (SV1 + 
RV5-6 > 38 mm) or the product of QRS duration times Cornell voltage (with adjustment of 6 
mm in women and a partition value of > 2440 mm × ms) are independent predictors of 
cardiovascular events (Levy et al, 1994). Their use as markers of cardiac damage or 
regression induced by treatment appears to be valuable, at least in patients over 55 years 
(Okin et al, 2004, Fagard et al, 2004). ECG can also be used to detect patterns of ventricular 
overload (indicating a severe risk) (Levy et al, 1994), ischemia, conduction disturbances and 
arrhythmias, including atrial fibrillation, not rare in elderly hypertensive patients. Holter 
electrocardiographic monitoring is indicated to detect hypertension when arrhythmias or 
ischemic episodes exist. It may also provide evidence of reduced heart rate variability, 
which can occur in severe hypertension (Mancia et al, 1983). However, its negative 
prognostic significance is not established, although it has been demonstrated for heart 
failure and post infarction (Kleiger et al, 1987, Bigger et al, 1992, La Rovere et al, 2003).  
Echocardiography is more sensitive than electrocardiography in diagnosing left ventricular 
hypertrophy, in cardiovascular risk prediction and may help stratify global 
cardiovascular risk more precisely and establish therapy, although it has some technical 
limitations (differences between operators, poor image quality in obese patients and in 
patients with obstructive lung disease) (Reichek et al, 1981; Levy et al, 1990). A proper 
assessment includes measuring the dimensions of interventricular septum, posterior wall 
thickness and left ventricular end diastolic diameter of left ventricular to left ventricular 
mass calculation according to Devereux formula (Devereux et al, 1986). Although the 
relationship between left ventricular mass index and cardiovascular risk is linear, the 
estimates of left ventricular hypertrophy are widely used: > 134 g/m2 for men and > 110 
g/m2 for women (Hammond, 1986). Concentric hypertrophy (increased left ventricular 
mass and relative wall thickness ratio >0.45), eccentric hypertrophy (relative wall 
thickness ratio < 0.42, with increased left ventricular mass) and concentric remodeling 
(relative wall thickness ratio ≥ 0.42, with normal left ventricular mass), are predictors for 
increased incidence of cardiovascular disease, but concentric hypertrophy is shown to 
provide the most cardiovascular risk increase (Jennings et al, 1997; Muiesan et al, 2004). A 
major advantage of echocardiography compared with ECG is better sensitivity, enabling 
the detection of milder degrees of LVH (Waeber, 2009). In addition, echocardiography 
provides a method to assess left ventricular systolic function. Ejection fraction, fractional 
shortening as medio-parietal endocardial and were proposed as possible additional 
predictors of cardiovascular events (De Simone, 1996; Aurigemma, 2001). Left ventricular 
diastolic filling (a measure of so-called "diastolic function") can be assessed by measuring 
the ratio wave Doppler E/A of transmitral blood flow, time to relax, protodiastolic 
pulmonary venous flow and left atrial enlargement (Swedberg, 2005). Useful information 
can be obtained by tissue Doppler at the mitral ring (Ogunyankin, 2006). All these 
determinations arouse great interest at present, because a considerable proportion (50%) 
of heart failures can be explained by "diastolic dysfunction" with an impaired systolic 
minimum and that the so-called „diastolic heart failure "is a condition with adverse 
prognosis. Alterations in diastolic function are common in hypertensive and elderly 
subjects with hypertension, at least one in four patients may be affected (Zanchetti, 2006). 
These changes may occur in the absence of systolic function alterations and even without 
left ventricular hypertrophy. There is evidence that diastolic dysfunction increases the 
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risk of atrial fibrillation (Tsang, 2004). Furthermore, two studies have reported that 
diastolic dysfunction is predictive factor for subsequent heart failure (Aurigemma, 2001) 
and is associated with an increased incidence of mortality (Redfield, 2003), although in 
another study it was shown that this combination is not independent (Bella et al, 2002). 
Echocardiography provides information about the presence and degree of left atrial 
dilation, which correlates with risk of atrial fibrillation, cardiovascular disease and death 
(Laukkanen, 2005; Verdecchia, 2003; Kizer, 2006). Also, data can be obtained by kinetic 
abnormalities of left ventricular segmentation, due to ischemia or previous infarction. A 
regression of left-ventricular hypertrophy on electrocardiography is indicative of 
substantial clinical benefit and should be an important objective of treatment (Devereaux, 
2004; Okin, 2004). 
4. Hypertension-induced renal damage 
Diagnosis of hypertension-induced renal damage is based on the discovery of a reduced 
renal function and/or increased urinary albumin excretion detection (Stevens et al, 2006). 
Renal failure is now classified according to glomerular filtration rate, calculated by MDRD 
formula that includes age, gender, and race and serum creatinine of the patient (Hallan, 
2004). Glomerular filtration rate values below 60 ml/min/1,73 m2 indicate chronic kidney 
disease stage 3, while values below 30 ml min/l,73 m2 indicate chronic kidney disease stage 
4, and values below 15 ml/min/l,73 m2 indicate chronic kidney disease stage 5 (Moe, 2005). 
Cockroft-Gault formula estimates creatinine clearance and is based on age, sex, weight and 
patient's serum creatinine (Cockroft and Gault, 1976). This formula is used for values > 60 
ml/min, but it overestimates creatinine clearance in chronic kidney disease stage 3-5 (Moe et 
al, 2005). Both formulas are helpful in the detection of renal function slightly altered, where 
serum creatinine is still within normal limits (Moe et al., 2005). Reduced glomerular 
filtration rate and increased cardiovascular risk are also suggested by elevated levels of 
cystatin C (Shlipak, 2006). A slight increase in serum creatinine (up to 20%) can sometimes 
occur when initiating or changing antihypertensive therapy, but it should not be considered 
as a sign of progressive renal damage. Hyperuricemia is common in untreated 
hypertensives and has been shown to correlate with decreased renal flow and the presence 
of nephrosclerosis (Viazzi, 2007). While serum creatinine concentration increased or 
decreased estimated glomerular filtration rate shows a decrease in glomerular filtration rate, 
increased urinary excretion of albumin or protein indicates deterioration in the permeability 
of the glomerular filtration barrier.  
Microalbuminuria was associated with a cluster of metabolic and nonmetabolic risk factors, 
suggesting that it might indicate the presence of generalized microvascular damage in 
patients with essential hypertension (Pontremoli, 1998). It was shown that 
microalbuminuria is also a predictor of diabetic nephropathy development in type 1 and 2 
diabetes (Parving, 1996), while the presence of proteinuria indicates, in general, the 
existence of renal parenchymal lesions. In diabetic and non-diabetic hypertensive patients, 
microalbuminuria is a good predictor of cardiovascular events. It has been reported in some 
studies a linear relationship between non-cardiovascular mortality and cardiovascular and 
urinary protein ratio/creatinine > 3.9 mg/g in men and 7.5 mg/g in women. Thus the term 
microalbuminuria may be misleading (for falsely suggests a minor injury) and should be 
replaced with "low degree of albuminuria." Microalbuminuria can be measured by urinary 
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albumin concentration reporting urinary creatinine concentration (urine samples per 24 
hours or the night should be discouraged because of lack of accuracy), type dipstick tests 
detect albuminuria above 300 mg/g creatinine and positive dipstick test for 
microalbuminuria in values above 30 mg/g creatinine. Microalbuminuria assessment is  
now recommended at the initial evaluation of a patient with hypertension. Two first-
morning voided urine samples should be tested for the albumin/creatinine ratio (Redon, 
2008). Microalbuminuria assessment is now recommended in a risk stratification strategy for 
hypertension management, since its presence indicates early organ damage and, rarely, a 
clustering of cardiovascular risk factors (Mancia, 2007). 
5. Hypertension-induced brain damage 
Until now, preclinical hypertensive lesions in the brain have not been well characterized. 
Microcirculation dysfunction may explain the deterioration in cognitive functions in 
hypertensive subjects (Cohuet, 2006). Cognitive deterioration and its end point overt 
dementia are, in brief, to be characterized by progressive memory loss, disorientation in 
time and space, loss of autonomy, and ultimately, depersonalisation/alienation 
(Birkenhäger, 2006). Consensus criteria recognize various syndromes, including multiple 
cerebral infarcts (large vessel infarcts), single infarcts, small vessel disease (multiple lacunes 
dementia), global hypoperfusion, and hemorrhagic dementia in the pathogenesis of vascular 
dementia (Cohuet, 2006). Silent brain infarction, which is cerebral target organ damage of 
hypertensive microangiopathies, is frequently seen in hypertensive patients (Kwon, 2007). 
Indeed, the degree of risk for hypertension-induced cerebrovascular disease increases 
progressively with the rise in BP levels (Wolf, 1991). An increased risk for cerebrovascular 
events in uncomplicated patients with hypertension and LVH diagnosed using both 
electrocardiography and echocardiography was demonstrated in the Progetto 
Ipertensione Umbria Monitoraggio Ambulatoriale (PIUMA) study (Verdecchia, 2001). A 
close association has also been shown between silent stroke (evidenced by cerebral white 
matter lesions) and echocardiographic LVH in 62 asymptomatic middle-aged patients 
with hypertension (Sierra, 2002). Many epidemiologic studies have indicated a correlation 
between blood pressure level and cognitive decline or dementia later in life (Starr, 1993; 
Seux, 1998; Postner, 2002; Hanon, 2003; Piguet, 2003; Whitmer, 2005). The importance of 
lowering blood pressure in hypertensive subjects is well-known, but the relationship 
between hypertension and cognitive function is still controversial. It is believed that 
atherosclerosis resulting from long-standing hypertension, and cerebral hypoperfusion 
secondary to severe atherosclerosis may be major biological pathways linking both high 
blood pressure in midlife and low blood pressure in late-life to cognitive decline and 
dementia (Qiu, 2005). 
6. Conclusion 
Signs of target organ damage (TOD) should be carefully detected in all hypertensive 
patients because the likelihood of identifying high-risk individuals increases. Detection of 
any subclinical target organ damage in the coronary, peripheral, cerebral, and renal arterial 
beds requires therapeutic objectives and strategies in order to induce regression and 
improve patient prognosis.  
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